基于表面的多轴纵向解使用对比学习用于阿尔茨海默病的疾病
Jianwei Zhang1,2, Yonggang Shi1,2
1Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA 90033, USA.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention
|December 4, 2025
概括
这项研究引入了一种新的深度学习方法,通过将衰老影响与疾病变化分开,更好地模拟阿尔茨海默病 (AD) 的进展. 多轴方法捕捉了AD的复杂性,提高了诊断准确度.
科学领域:
- 神经科学是一个神经科学.
- 人工智能的人工智能
- 医疗成像医学成像
背景情况:
- 对阿尔茨海默病 (AD) 进展的准确建模对于理解神经病理学至关重要.
- 神经成像分析往往难以区分疾病影响与正常衰老.
- 目前用于解开纵向数据的深度学习方法在捕获AD异质性方面存在局限性.
研究的目的:
- 开发一种新的基于表面的多轴解框架,用于建模阿尔茨海默病的进展.
- 增强深度学习模型的能力,以捕捉AD的多面性质和多样性轨迹.
- 为了更好地将衰老效应与疾病特异性变化的分离,在纵向神经影像数据中.
主要方法:
- 提出了使用自动编码器网络的基于表面的多轴解框架.
- 实施了具有自我监督的纵向对比损失,以将数据轨迹分配给多个疾病轴,而没有明确的标签.
- 评估了阿尔茨海默病神经成像计划 (ADNI) 数据集 (N=1321) 上的模型.
主要成果:
- 多轴模型在区分认知正常 (CN),轻度认知障碍 (MCI) 和AD患者方面表现出卓越的表现.
- 与单轴模型相比,实现了稳定的MCI与转换MCI和粉样状况的改进分类.
- 一项废除研究证实了对比性损失在捕获复杂的AD进展模式方面的有效性.
结论:
- 拟议的多轴解框架有效地模拟了阿尔茨海默病的异质进展.
- 与传统的单轴方法相比,这种方法提供了对疾病轨迹的更细致的理解.
- 该框架在阿尔茨海默病研究中有望改善差异诊断和跟踪疾病进展.
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764